{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:01:01Z","timestamp":1781499661931,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Health care-associated urinary tract infection (HAUTI) consists of unique conditions (cystitis, pyelonephritis and urosepsis). These conditions could have different pathogen diversity and antibiotic resistance impacting on the empirical antibiotic choices. The aim of this study is to compare the estimated chances of coverage of empirical antibiotics between conditions (cystitis, pyelonephritis and urosepsis) in urology departments from Europe.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A mathematical modelling based on antibiotic susceptibility data from a point prevalence study was carried. Data were obtained for HAUTI patients from multiple urology departments in Europe from 2006 to 2017. The primary outcome of the study is the Bayesian weighted incidence syndromic antibiogram (WISCA) and Bayesian factor. Bayesian WISCA is the estimated chance of an antibiotic to cover the causative pathogens when used for first-line empirical treatment. Bayesian factor is used to compare if HAUTI conditions did or did not impact on empirical antibiotic choices.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Bayesian WISCA of antibiotics in European urology departments from 2006 to 2017 ranged between 0.07 (cystitis, 2006, Amoxicillin) to 0.89 (pyelonephritis, 2009, Imipenem). Bayesian WISCA estimates were lowest in urosepsis. Clinical infective conditions had an impact on the Bayesian WISCA estimates (Bayesian factor\u2009&gt;\u20093 in 81% of studied antibiotics). The main limitation of the study is the lack of local data.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our estimates illustrate that antibiotic choices can be different between HAUTI conditions. Findings can improve empirical antibiotic selection towards a personalized approach but should be validated in local surveillance studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00345-019-02963-9","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:03:11Z","timestamp":1569430991000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-3656","authenticated-orcid":false,"given":"Zafer","family":"Tandogdu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Koves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls Erik Bjerklund","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"issue":"8","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00345-015-1722-1","volume":"34","author":"Z Tandogdu","year":"2016","unstructured":"Tandogdu Z et al (2016) Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003\u20132013. World J Urol 34(8):1193\u20131200","journal-title":"World J Urol"},{"issue":"1","key":"2963_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhin.2016.08.010","volume":"95","author":"Y Chen","year":"2017","unstructured":"Chen Y et al (2017) A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals. J Hosp Infect 95(1):105\u2013111","journal-title":"J Hosp Infect"},{"issue":"13","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198\u20131208","journal-title":"N Engl J Med"},{"issue":"46","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"20316","DOI":"10.2807\/ese.17.46.20316-en","volume":"17","author":"P Zarb","year":"2012","unstructured":"Zarb P et al (2012) The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance 17(46):20316","journal-title":"Eurosurveillance"},{"issue":"5","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA (2008) CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309\u2013332","journal-title":"Am J Infect Control"},{"issue":"1","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/sur.2005.6.41","volume":"6","author":"PS Barie","year":"2005","unstructured":"Barie PS et al (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6(1):41\u201354","journal-title":"Surg Infect (Larchmt)"},{"issue":"1","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1378\/chest.118.1.146","volume":"118","author":"EH Ibrahim","year":"2000","unstructured":"Ibrahim EH et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146\u2013155","journal-title":"Chest"},{"issue":"5","key":"2963_CR8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1378\/chest.09-0087","volume":"136","author":"A Kumar","year":"2009","unstructured":"Kumar A et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136(5):1237\u20131248","journal-title":"Chest"},{"issue":"8","key":"2963_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jama.2017.0131","volume":"317","author":"MD Howell","year":"2017","unstructured":"Howell MD, Davis AM (2017) Management of sepsis and septic shock. JAMA 317(8):847\u2013848","journal-title":"JAMA"},{"issue":"12","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1128\/AAC.01638-15","volume":"59","author":"K Linsenmeyer","year":"2015","unstructured":"Linsenmeyer K, Strymish J, Gupta K (2015) Two simple rules for improving the accuracy of empiric treatment of multidrug-resistant urinary tract infections. Antimicrob Agents Chemother 59(12):7593\u20137596","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2963_CR11","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1128\/AAC.00565-10","volume":"54","author":"D Marchaim","year":"2010","unstructured":"Marchaim D et al (2010) National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae\u2009producing extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother 54(12):5099\u20135104","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2963_CR12","doi-asserted-by":"publisher","first-page":"e012675","DOI":"10.1136\/bmjopen-2016-012675","volume":"6","author":"M Gharbi","year":"2016","unstructured":"Gharbi M et al (2016) Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open 6(11):e012675","journal-title":"BMJ Open"},{"issue":"3","key":"2963_CR13","doi-asserted-by":"publisher","first-page":"e014538","DOI":"10.1136\/bmjopen-2016-014538","volume":"7","author":"M N\u00fa\u00f1ez-N\u00fa\u00f1ez","year":"2017","unstructured":"N\u00fa\u00f1ez-N\u00fa\u00f1ez M et al (2017) Surveillance systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review. BMJ Open 7(3):e014538","journal-title":"BMJ Open"},{"issue":"4","key":"2963_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/664768","volume":"33","author":"C Hebert","year":"2012","unstructured":"Hebert C et al (2012) Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol 33(4):381\u2013388","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"2963_CR15","doi-asserted-by":"publisher","first-page":"e0214710","DOI":"10.1371\/journal.pone.0214710","volume":"14","author":"Z Tandogdu","year":"2019","unstructured":"Tandogdu Z et al (2019) Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: a Bayesian analytical approach applied in a surveillance study. PLoS One 14(4):e0214710","journal-title":"PLoS One"},{"issue":"3","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.artmed.2015.08.004","volume":"65","author":"S Andreassen","year":"2015","unstructured":"Andreassen S et al (2015) Interpretative reading of the antibiogram\u2013a semi-naive Bayesian approach. Artif Intell Med 65(3):209\u2013217","journal-title":"Artif Intell Med"},{"issue":"3","key":"2963_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/jac\/dkv397","volume":"71","author":"JA Bielicki","year":"2016","unstructured":"Bielicki JA et al (2016) Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. J Antimicrob Chemother 71(3):794\u2013802","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pathogens5010010","volume":"5","author":"F Wagenlehner","year":"2016","unstructured":"Wagenlehner F et al (2016) The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 5(1):10","journal-title":"Pathogens"},{"key":"2963_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511623387","volume-title":"Species diversity in space and time","author":"ML Rosenzweig","year":"1995","unstructured":"Rosenzweig ML (1995) Species diversity in space and time. Cambridge University Press, Cambridge"},{"issue":"1","key":"2963_CR20","first-page":"2","volume":"7","author":"FJ Andrew","year":"2014","unstructured":"Andrew FJ, Jennifer W (2014) What are the odds? a practical guide to computing and reporting Bayes factors. J Prob Solving 7(1):2","journal-title":"J Prob Solving"},{"key":"2963_CR21","volume-title":"Surveillance of antimicrobial resistance in Europe\u2014annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","author":"ECDP","year":"2018","unstructured":"ECDP (2018) Surveillance of antimicrobial resistance in Europe\u2014annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. European Centre for Disease Prevention and Control, Stockholm"},{"key":"2963_CR22","unstructured":"Bonkat G, Bartoletti RR, Bruy\u00e8re F, Cai T, Geerlings SE, K\u00f6ves B, Schubert S, Wagenlehner F, Guidelines Associates: Mezei T, Pilatz A, Pradere B, Veeratterapillay R, Members of the EAU \u2013 ESIU Infections in Urology Guidelines Panel (2019) EAU \u2013 ESIU Guidelines on Infections in Urology. Edition presented at the EAU Annual Congress Copenhagen. EAU Guidelines Office, Arnhem. ISBN 978-94-92671-02-8"},{"key":"2963_CR23","volume-title":"Theory of probability","author":"H Jeffreys","year":"1961","unstructured":"Jeffreys H (1961) Theory of probability, 3rd edn. Oxford University Press, Oxford","edition":"3"},{"issue":"1","key":"2963_CR24","doi-asserted-by":"publisher","first-page":"e86634","DOI":"10.1371\/journal.pone.0086634","volume":"9","author":"M Koningstein","year":"2014","unstructured":"Koningstein M et al (2014) Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands. PLoS One 9(1):e86634","journal-title":"PLoS One"},{"issue":"9761","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","volume":"377","author":"B Allegranzi","year":"2011","unstructured":"Allegranzi B et al (2011) Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377(9761):228\u2013241","journal-title":"Lancet"},{"issue":"8","key":"2963_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ajic.2010.04.211","volume":"38","author":"MF Niedner","year":"2010","unstructured":"Niedner MF, NAC Hospitals and RIPICUPCF Group (2010) The harder you look, the more you find: Catheter-associated bloodstream infection surveillance variability. Am J Infect Control 38(8):585\u2013595","journal-title":"Am J Infect Control"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02963-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T01:37:35Z","timestamp":1600911455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02963-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02963-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"21 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval was obtained centrally from Giessen University, Germany (in supplemental material). Local investigators were responsible to obtain any further ethical approval if required by their local jurisdiction.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This research does not involve any interventions to human participants. The study is conducted as a surveillance study and is not involved as part of an intervention.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}